Deals & regulation
CVS plans to separate its pharmacy business from Aetna and Caremark
CVS Health plans to split its 9,000 pharmacies, clinics and mail-order prescription operations into a company called CVS Pharmacy, while retaining Aetna, Caremark and other care businesses in CVS Health. The planned separation, targeted for early 2028, reverses the conglomerate strategy that followed CVS’s 2018 acquisition of Aetna. It comes as lawmakers and regulators scrutinize the concentration of insurers, pharmacy-benefit managers and pharmacies, although the report does not establish whether the breakup will lower costs for patients.
Editorial summary · Publisher article
What matters
- The pharmacy company would include retail stores, in-store clinics and mail-order prescriptions.
- Aetna and Caremark would remain in the company retaining the CVS Health name.
- CVS says the move is intended to improve affordability, access and simplicity.
- The company previously opposed legislative efforts to break it apart.
Context & caveats
- The separation is planned rather than completed, and its effects on prices, competition and patients remain uncertain.
Why this made the edition
The report provides a concrete proposed corporate separation, business-unit details, regulatory context, prior acquisition history and a target date. It also preserves the company’s stated rationale and the surrounding antitrust debate.
Source material